New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
Vertex Pharmaceuticals on Monday won approval for its fourth treatment for cystic fibrosis, a combination drug that extends a new form of therapy to 90% of CF patients.
The drug will be marketed as Trikafta. The list price
